Politics Could Get In Way Of Quick Decision On New EMA Home
An early decision on the new home for the European Medicines Agency would help to minimize the level of disruption that will be involved in moving the agency from London to somewhere else in Europe when the UK leaves the EU. The EMA and the European Parliament have both called for quick resolution on this, but what you want is not always what you get.
You may also be interested in...
The criteria for cities wanting to host the European Medicines Agency post Brexit should be formally agreed in June and the agency’s new location could be decided in October. There are concerns that, if the decision is left any longer, it will be hard for the EMA to move in the time remaining before the UK leaves the EU.
The European Commission has produced draft Brexit negotiating directives in which it suggests that the UK should bear the cost of moving the European Medicines Agency from London to elsewhere in the EU. Meanwhile, the criteria for choosing a new host country for the EMA are expected to be discussed at a meeting of heads of state at the end of April.
The EMA has outlined some of the planning that has been going on in preparation for its relocation from the UK to another EU member state as a result of Brexit, including ongoing relations with the UK regulator, the MHRA.